ReviewAmerican journal of respiratory and critical care medicine2022
Extracorporeal Membrane Oxygenation during Respiratory Pandemics: Past, Present, and Future.
Review in American journal of respiratory and critical care medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Short-term outcome of veno-venous extracorporeal membrane oxygenation in patients of acute respiratory distress syndrome presenting at a tertiary care centre - An observational study.Lung India : official organ of Indian Chest Society · 2026Article
- Outcome of Emergency Pulmonary Lobectomy under ECMO Support in Patients with COVID-19.The Thoracic and cardiovascular surgeon · 2026Article
- A compact machine perfusion device for whole blood perfusion in isolated rat liver.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Article
- Health Resource Utilization and Outcomes Among Patients Who Receive Extracorporeal Membrane Oxygenation.CJC open · 2025Review
- Article
- Extracorporeal Membrane Oxygenation (ECMO): A Lifeline for Pregnant and Postpartum Women.Cureus · 2023Review
- Timing of Lung Transplant Referral in Patients with Severe COVID-19 Lung Injury Supported by ECMO.Journal of clinical medicine · 2023Article
- The Use of Extracorporeal Membrane Oxygenation for COVID-19: Lessons Learned.Clinics in chest medicine · 2023Review
- Extracorporeal Membrane Oxygenation Then and Now; Broadening Indications and Availability.Critical care clinics · 2023Review
- Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review.Journal of intensive care · 2023Review
- Discontinuation of ECMO-a review with a note on Indian scenario.Indian journal of thoracic and cardiovascular surgery · 2023Review
- Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.The Lancet. Respiratory medicine · 2023Article
- Introduction to the Special Issue-Cardiothoracic Surgical Critical Care: A Future of Distinction.Medicina (Kaunas, Lithuania) · 2022Article
- Respiratory indications for ECMO: focus on COVID-19.Intensive care medicine · 2022Review
- Ethical Considerations in Ever-Expanding Utilization of ECLS: A Research Agenda.Frontiers in pediatrics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of extracorporeal membrane oxygenation (ECMO) in the management of severe acute respiratory failure, including acute respiratory distress syndrome, has become better defined in recent years in light of emerging high-quality evidence and technological advances. Use of ECMO has consequently increased throughout many parts of the world. The coronavirus disease (COVID-19) pandemic, however, has highlighted deficiencies in organizational capacity, research capability, knowledge sharing, and resource use. Although governments, medical societies, hospital systems, and clinicians were collectively unprepared for the scope of this pandemic, the use of ECMO, a highly resource-intensive and specialized form of life support, presented specific logistical and ethical challenges. As the pandemic has evolved, there has been greater collaboration in the use of ECMO across centers and regions, together with more robust data reporting through international registries and observational studies. Nevertheless, centralization of ECMO capacity is lacking in many regions of the world, and equitable use of ECMO resources remains uneven. There are no widely available mechanisms to conduct large-scale, rigorous clinical trials in real time. In this critical care review, we outline lessons learned during COVID-19 and prior respiratory pandemics in which ECMO was used, and we describe how we might apply these lessons going forward, both during the ongoing COVID-19 pandemic and in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.